Voting opens for CIMIA People's Choice Award


Monday, 03 September, 2018


Voting opens for CIMIA People's Choice Award

Voting for the People’s Choice Award in the 2018 Centenary Institute Medical Innovation Award (CIMIA) is now open.

Some of the entries for this year’s awards include projects using computational models to eliminate Hepatitis C, learning how to switch drug-resistant melanoma into drug-sensitive melanoma, boosting the brain’s reward system to treat anorexia and investigating a potential link between gut bacteria and breast cancer.

These projects can be viewed on the 2018 Centenary Institute Medical Innovation Awards page, where members of the public can choose their favourite by clicking on the ‘Vote’ button on the individual entry pages.

The entry with the most votes will be crowned winner of the People’s Choice Award and will take home a $2000 cheque to help them continue their innovative research. Voting for this category closes on Sunday, 16 September.

In addition to this prize, all entries will be carefully considered by a panel of internationally renowned judges to determine the overall winner and runners-up of the 2018 Centenary Institute Medical Innovation Awards, which will be announced at a ceremony in Sydney on Wednesday, 3 October.

The winner of the In-Memory of Neil Lawrence Prize will receive $30,000 from Commonwealth Private to support their project and a perpetual Nick Mount hand blown glass trophy. Second place and third place will receive $15,000 and $10,000 respectively, thanks to Bayer and Val Morgan.

“Exceptional young scientists can be hard to keep in Australia and we hope this award will not only celebrate their achievements but also encourage a domestic culture of brilliance in medical research,” said Centenary Institute Executive Director Mathew Vadas AO.

Image credit: ©stock.adobe.com/au/vege

Related News

Agilent expands cell analysis portfolio with BioTek acquisition

Agilent Technologies has signed a definitive agreement to acquire the privately owned BioTek...

IDT and 3CR collaborate on custom genotyping service

The partnership fuses IDT's oligo synthesis with 3CR's PACE Genotyping Master Mix and...

$6m investment in WA space sector

Western Australia will play a key role in the Australian Space Agency's efforts to triple the...


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd